424B4·October 23, 2026 at 4:11 PM EDT·1 source
Lycia Therapeutics, Inc. prices its offering
LYCA
SEC filing
What happened
- Lycia Therapeutics, Inc. filed a 424B4 with the SEC on October 23, 2026.
- The filing states that Lycia Therapeutics’ IPO was priced.
Why it matters
The pricing marks a completed IPO event for healthcare equity-capital-markets professionals. The source provides no offering size, price or other transaction terms.
Deal terms
ipo
Lycia Therapeutics, Inc.
Value
—
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- EarlierOct 23Food Allergy Biotech Firm Lycia Jumps 32% After Upsized IPO
- IPO pricing (424B4)Oct 23Lycia Therapeutics, Inc. prices its offering
Who is involved
Lycia Therapeutics, Inc. prices its offeringLycia Therapeutics, Inc.LYCA · targetSEC
CompanyAgency
Sources (1)
- SEC EDGAROct 23Lycia Therapeutics, Inc. prices its offering
Related
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.